IDENTIFICATION OF POTENT DUAL OREXIN RECEPTOR ANTAGONISTS

被引:0
|
作者
Coleman, Paul J. [1 ]
Schreier, John D. [1 ]
Cox, Christopher D. [1 ]
Breslin, Michael J. [1 ]
Whitman, David B. [1 ]
Roecker, Anthony J. [1 ]
Bogusky, Michael J. [1 ]
Bednar, Rodney A. [1 ]
Lemaire, Wei [1 ]
Bruno, Joseph C. [1 ]
Hartman, George D. [1 ]
McGaughey, Georgia B. [1 ]
Reiss, Duane R. [2 ]
Harrell, C. Meacham [2 ]
Doran, Scott M. [2 ]
Garson, Susan L. [2 ]
Kraus, Richard L. [2 ]
Li, Yuxing [2 ]
Prueksaritanont, Thomayant [3 ]
Li, Chunze [3 ]
Winrow, Christopher J. [2 ]
Koblan, Kenneth S. [2 ]
Renger, John J. [2 ]
机构
[1] Merck Res Labs, Dept Med Chem, West Point, PA USA
[2] Merck Res Labs, Dept Depress & Circadian Disorders, West Point, PA USA
[3] Merck Res Labs, Dept Drug Metab, West Point, PA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:10 / 11
页数:2
相关论文
共 50 条
  • [41] GPCR structure-based drug discovery: Identification of dual orexin antagonists and orexin-1 selective antagonists for the treatment of insomnia and addiction disorders
    Christopher, John A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [42] Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
    Besterman, Aaron D.
    Jeste, Shafali S.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2023, 32 (03) : 527 - 531
  • [43] Novel therapeutic class for insomnia treatment: Dual orexin receptor antagonists - it is worth to prescribe it?
    Nogueira, J.
    Ribeiro, R.
    Mendes, S.
    Gamito, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S515 - S515
  • [44] Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
    Aaron D. Besterman
    Shafali S. Jeste
    European Child & Adolescent Psychiatry, 2023, 32 : 527 - 531
  • [45] Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
    Xue, Tao
    Wu, Xin
    Li, Jiaxuan
    Chen, Shujun
    Wang, Zilan
    Tan, Xin
    Wang, Zhong
    Zhang, Jianguo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
    Gotter, Anthony L.
    Winrow, Christopher J.
    Brunner, Joseph
    Garson, Susan L.
    Fox, Steven V.
    Binns, Jacquelyn
    Harrell, Charles M.
    Cui, Donghui
    Yee, Ka Lai
    Stiteler, Mark
    Stevens, Joanne
    Savitz, Alan
    Tannenbaum, Pamela L.
    Tye, Spencer J.
    McDonald, Terrence
    Yao, Leon
    Kuduk, Scott D.
    Uslaner, Jason
    Coleman, Paul J.
    Renger, John J.
    BMC NEUROSCIENCE, 2013, 14
  • [47] Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
    Anthony L Gotter
    Susan L Garson
    Joanne Stevens
    Regina L Munden
    Steven V Fox
    Pamela L Tannenbaum
    Lihang Yao
    Scott D Kuduk
    Terrence McDonald
    Jason M Uslaner
    Spencer J Tye
    Paul J Coleman
    Christopher J Winrow
    John J Renger
    BMC Neuroscience, 15
  • [48] Orexin receptor antagonists: a new treatment for insomnia?
    Riemann, Dieter
    Spiegelhalder, Kai
    LANCET NEUROLOGY, 2014, 13 (05): : 441 - 443
  • [49] Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists
    Fujimoto, Tatsuhiko
    Kunitomo, Jun
    Tomata, Yoshihide
    Nishiyama, Keiji
    Nakashima, Masato
    Hirozane, Mariko
    Yoshikubo, Shin-ichi
    Hirai, Keisuke
    Marui, Shogo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6414 - 6416
  • [50] Opportunities and perspectives for developing orexin receptor antagonists
    Barnes, Nicholas M.
    FRONTIERS IN NEUROSCIENCE, 2014, 8